Patricia Lobo

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar”.

Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104025

N/A

2.9DataRank · unranked

62 citations

Brian G. Weinshenker, Michael R. Yeaman, de Sèze, Francesco Patti, Patricia Lobo +5 more